Rep. Kevin Hern (R-Okla.) has disclosed a sale of Colgate-Palmolive Company common stock (NYSE: CL), according to a Periodic Transaction Report filed under the STOCK Act. The transaction, dated August 19, 2026, was made through a jointly-held account belonging to Hern and his spouse, and is valued in the disclosed range of $1,001 to $15,000. The filing lists the holding as being maintained through the Hern Family Foundation, the vehicle through which the couple’s brokerage account is structured.
The STOCK Act requires members of Congress and their immediate family to disclose transactions in stocks, bonds, and other securities within 30 to 45 days of execution. These filings are intended to give the public visibility into potential financial interests that could intersect with legislative work, and they are a routine part of congressional financial reporting. A disclosure of this kind is not an allegation of wrongdoing; it simply reflects a legal reporting obligation tied to holdings inside a jointly-owned account.
A Notable Overlap in Timing
What makes this filing worth tracking is its proximity to another CL-related transaction reported separately. Company insider Tsourapas Panagiotis also sold shares of Colgate-Palmolive stock, in a transaction dated August 24, 2026, valued at $920,477. That sale falls within roughly a week of Hern’s disclosed transaction date, and both events sit within the same 30-day window our system flags for cross-signal review.
Whoisbuyingnow.com classifies the congressional filing as a ‘congress sale’ signal, one of several categories we use to track disclosed activity by lawmakers. When a member-level sale and a company insider sale of the same security occur close together, we surface that overlap because it can be a useful data point for readers monitoring sentiment around a particular stock, even though the two filings originate from entirely separate disclosure systems, one under the STOCK Act for members of Congress, the other under SEC insider-trading rules for corporate insiders like Tsourapas.
There is no public information tying the two transactions together beyond the shared ticker and the closeness of their dates. Insider sales at companies like Colgate-Palmolive happen for a wide range of routine reasons, including diversification, tax planning, or scheduled trading plans, and the same holds true for family-held brokerage accounts tied to a member of Congress. Readers are encouraged to view this as a disclosure-tracking data point rather than a signal of any particular market outlook.
Additional details on this transaction, including the full text of the filing, are available in the underlying House disclosure record.